| Literature DB >> 35754052 |
Safari Joseph Balegamire1,2, Elisabeth McClymont3, Agathe Croteau4, Philippe Dodin5, Soren Gantt5,6, Amir Abbas Besharati5, Christian Renaud5,6, Benoît Mâsse7,8, Isabelle Boucoiran7,5,9.
Abstract
BACKGROUND: Cytomegalovirus (CMV) is transmitted by direct contact with body fluids from infected individuals. Transmission of CMV in households, particularly those with young children, contributes significantly to CMV infection in the general population. However, little is known about the contribution of occupational healthcare or childcare exposure to risk of CMV infection.Entities:
Keywords: Childcare; Cytomegalovirus; Day care; Healthcare workers; Incidence; Prevalence; Primary infection; Young children
Mesh:
Year: 2022 PMID: 35754052 PMCID: PMC9235282 DOI: 10.1186/s13643-022-02004-4
Source DB: PubMed Journal: Syst Rev ISSN: 2046-4053
Eligibility criteria
| Inclusion criteria | Exclusion criteria | |
|---|---|---|
| Population | Employable | Age less than 16 or older than 80 years, animals |
| Exposure | Possible occupational exposure to CMV: childcare and healthcare workers | |
| Control | No occupational exposure to CMV: jobs not related to childcare or health care | |
| Outcomes | Ia. CMV seroprevalence Ib. Incidence of CMV primary infection IIa. Seroprevalence odds ratio IIb. Seroconversion risk ratio III. Risk factor odds ratio | |
| Study design | Any original study including more than one participant | Case report, comment, letter to the editor, ecological study, meta-analysis, systematic review |
Fig. 1Flowchart describing the selection of studies on prevalence, incidence, and risk factors associated with CMV in childcare and healthcare workers
Seroprevalence and incidence of CMV infection among healthcare and childcare workers
| CMV seropositivity | CMV primary infection | |||||||
|---|---|---|---|---|---|---|---|---|
| Covariates | Number of studies | Sample size | Proportion % (95 % | Number of studies | Person-year | Incidence % per year (95% | ||
| Overall prevalence | 47 | 29332 | 53.3 (46.5–60.0) | 98 (98–98) | 21 | 3994 | 4.6 (2.6–7.1) | 83 (76–89) |
| Groups* | ||||||||
| Childcare workers | 24 | 22194 | 59.3 (49.8–68.6) | 98 (97–98) | 9 | 883 | 7.4 (3.9–11.8) | 89 (81–93) |
| Healthcare workers | 25 | 7138 | 49.5 (40.3–58.7) | 97 (97–98) | 12 | 3111 | 3.1 (1.3–5.6) | 48 (0–73) |
| Region | ||||||||
| Africa | 3 | 95 | 47.9 (18.5–78.0) | 96 (91–98) | - | |||
| North America | 26 | 6781 | 46.6 (37.9–55.5) | 94 (92–95) | 15 | 3272 | 5.9 (3.3–9.0) | 87 (80–91) |
| Asia | 2 | 1242 | 77.9 (49.1–96.8) | 91 (68–97) | 1 | 70 | 2.8 (0.0–8.4) | - |
| Europe | 15 | 20924 | 61.2 (50.2–71.7) | 99 (98–99) | 3 | 352 | 1.1 (0.0–7.4) | 15 (0–91) |
| Oceania | 1 | 290 | 52.1 (46.3–57.8) | 2 | 300 | 2.3 (0.0–10.3) | 62 (0–91) | |
| Diagnostic method | ||||||||
| Anticomplement immunofluorescence | 4 | 1466 | 60.5 (39.4–79.7) | 97 (95–98) | 3 | 1208 | 2.6 (0.1–7.3) | 17 ( 0–91) |
| Complement fixation | 7 | 1636 | 48.6 (31.4–65.9) | 98 (97–99) | 5 | 1178 | 4.4 (1.2–9.2) | 72 (29–89) |
| ELISA | 18 | 5245 | 53.1 (42.7–63.3) | 98 (95–97) | 5 | 1169 | 5.0 (1.8–9.5) | 93 (88–97) |
| Latex agglutination | 6 | 795 | 47.0 (28.9–65.5) | 90 (81–95) | 4 | 258 | 7.9 (2.8–15.1) | 0 (0–85) |
| No specify | 3 | 644 | 24.6 (7.1–48.0) | 98 (97–99) | 1 | 42 | 23.8 (12.0–38.0) | - |
| Other | 7 | 19496 | 66.0 (50.4–80.1) | 95 (92–97) | 2 | 125 | 1.0 (0.0–7.1) | 45 (–) |
| Restriction endonuclease | 2 | 50 | 76.0 (41.3–98.8) | 42 (–) | 1 | 14 | 0.0 (0.0–11.9) | - |
| Study design | ||||||||
| Cohort | 25 | 7548 | 52.1 (42.8–61.3) | 97 (97–98) | 21 | 3994 | 4.6 (2.6–7.1) | 83 (76–89) |
| Cross-sectional | 22 | 21784 | 54.7 (44.6–64.6) | 98 (97–98) | - | |||
| Quality | ||||||||
| Good | 19 | 7584 | 58.9 (48.8–68.7) | 98 (97–98) | 10 | 2590 | 5.8 (2.7–9.8) | 88 (79–93) |
| Fair | 13 | 3160 | 51.1 (38.8–63.3) | 96 (95–97) | 8 | 1044 | 3.5 (0.7–7.8) | 67 (30–84) |
| Poor | 15 | 18588 | 46.7 (33.7–59.8) | 98 (97–98) | 3 | 359 | 3.9 (0.1–11.4) | 92 (80–97) |
CI Confidence interval, I2Statistic for heterogeneity. *Two studies included childcare and healthcare workers
Fig. 2Estimates of seroprevalence of CMV infection by geographical location. Overall CMV seroprevalence 53.3% (95% CI: 46.5–60.0). Bubble plots of CMV pooled seroprevalence in populations exposed to children in the workplace. Individual study data are shown at the country level and pooled by continent. The size of bubble is proportional to the number of participants studied
Fig. 3Pooled seroprevalence of CMV infection among childcare and healthcare workers
Fig. 4Pooled annual incidence of primary CMV infection
Comparison of CMV seropositivity and primary CMV infection rates in childcare and healthcare workers with controls
| Risk of CMV seropositivity | Risk of CMV primary infection | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Covariates | No. of studies | Exposed population | Nonexposed | OR (95% | No. of studies | Exposed population | Nonexposed | RR (95% | ||
| Overall | 13 | 3015 | 21202 | 1.4 (1.01–1.80) | 90 (85–93) | 9 | 1534 | 3085 | 2.1 (1.0–4.2) | 50 (0–78) |
| Groups | ||||||||||
| Childcare workers | 8 | 1933 | 16416 | 1.6 (1.2–2.3) | 83 (69–91) | 3 | 397 | 752 | 3.4 (1.3–8.8) | 55 (0–87) |
| Healthcare workers | 5 | 1082 | 4786 | 0.9 (0.6–1.2) | 61 (0–85) | 6 | 1137 | 2333 | 1.3 (0.6–2.7) | 1 (0–80) |
| Continent | ||||||||||
| America | 3 | 606 | 4592 | 0.8 (0.5–1.3) | 66 (0–90) | 6 | 1265 | 2874 | 2.4 (1.1–5.1) | 58 (0–83) |
| Europe | 10 | 2409 | 16610 | 1.5 (1.1–2.1) | 82 (68–90) | 2 | 229 | 193 | 1.0 (0.3–3.8) | - |
| Oceania | - | - | - | - | - | 1 | 40 | 18 | - | |
| Diagnostic method | ||||||||||
| Anticomplement immunofluorescence | 2 | 534 | 4535 | 1.1 (0.3–4.0) | 84 (35–96) | 1 | 175 | 1921 | 0.6 (0.2–1.9) | - |
| Complement fixation | - | - | - | - | - | 3 | 269 | 132 | 2.7 (0.7–10.6) | 0 (0–76) |
| ELISA | 6 | 1801 | 15616 | 1.3 (0.9–1.8) | 79 (53–90) | 4 | 1194 | 991 | 2.4 (0.8–7.2) | 66 (0–90) |
| Latex agglutination | - | - | - | - | - | 1 | 45 | 41 | 4.6 (0.2–92.5) | 0 |
| Other | 5 | 680 | 1051 | 1.7 (1.1–2.7) | 75 (39–90) | |||||
| Study design | ||||||||||
| Cohort | 5 | 930 | 5386 | 0.9 (0.7–1.3) | 69 (20–88) | |||||
| Cross-sectional | 8 | 2085 | 15816 | 1.6 (1.2–2.4) | 82 (66–91) | |||||
| Quality | ||||||||||
| Good | 6 | 1378 | 1209 | 1.3 (0.9–2.0) | 86 (73–93) | 4 | 952 | 909 | 3.8 (1.9–7.6) | 16 (0–87) |
| Fair | 6 | 1466 | 19764 | 1.2 (0.8–1.8) | 92 (85–95) | 4 | 542 | 2158 | 0.9 (0.4–2.7) | 0 |
| Poor | 1 | 171 | 229 | 2.6 (1.7–3.8) | - | 1 | 40 | 18 | - | - |
OR Odds ratio, RR Risk ratio, CI Confidence interval, I2Statistic for heterogeneity
Fig. 5Risk of CMV seropositivity among healthcare and childcare workers compared to controls
Fig. 6Risk ratio of primary CMV infection in healthcare and childcare workers compared to controls
Odds ratio for CMV seropositivity by risk factor among childcare and healthcare workers
| Covariates | Number of studies | Exposed population | Nonexposed | OR (95% | |
|---|---|---|---|---|---|
| Children at home (yes vs no) | 6 | 1000 | 947 | 2.0 (1.7–2.5) | 6 (0–76) |
| Childcare workers | 4 | 681 | 647 | 1.9 (1.3–2.7) | 37 (0–78) |
| Healthcare workers | 2 | 319 | 300 | 2.2 (1.6–3.8) | 0 |
| Race (others versus white) | 3 | 283 | 1154 | 2.3 (1.7–3.1) | 0 (0–89) |
| Marital status (married versus single) | 4 | 1237 | 683 | 1.7 (1.4–2.1) | 0 (0–70) |
| Age (30 years vs < 30 years) | 7 | 1247 | 922 | 1.4 (0.8–2.6) | 92 (86–95) |
| Childcare workers | 5 | 1023 | 638 | 1.1 (0.5–2.3) | 92 (85–96) |
| Healthcare workers | 2 | 225 | 284 | 2.6 (1.8–3.8) | 0 |
OR Odds ratio, CI Confidence interval, I2 Statistic for heterogeneity